You have 9 free searches left this month | for more free features.

Metastatic Nodes

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast

Enrolling by invitation
  • Breast Cancer Female
  • 99mTc-DARPinG3 SPECT/CT
  • Tomsk, Russian Federation
    Russia Tomsk NRMC
Jan 23, 2023

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Positron-Emission Tomography, Lymph Node Metastases, Thyroid Cancer Trial in Guangzhou (<Sup>18<Sup>F-FDG PET/CT dynamic scan,

Recruiting
  • Positron-Emission Tomography
  • +2 more
  • <Sup>18<Sup>F-FDG PET/CT dynamic scan
  • B-ultrasonography
  • Guangzhou, Guangdong, China
    Fifth Affiliated Hospital, Sun Yat-Sen University
Jul 27, 2022

Breast Cancer, Female Trial in Tomsk (ADAPT6-SPECT)

Recruiting
  • Breast Cancer
  • Female
  • Tomsk, Russian Federation
    Tomsk NRMC
Jun 7, 2022

Cervical Cancer Trial (CCRT, Surgical debulking of bulky or multiple lymph nodes)

Not yet recruiting
  • Cervical Cancer
  • CCRT
  • Surgical debulking of bulky or multiple lymph nodes
  • (no location specified)
Jul 19, 2022

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Hypopharyngeal Carcinoma Trial in China (drug, radiation, procedure)

Not yet recruiting
  • Hypopharyngeal Carcinoma
  • Beijing, Beijing, China
  • +3 more
Aug 9, 2022

Perihilar Cholangiocarcinoma Trial in Guangzhou (PD-1antibody plus GEMOX)

Not yet recruiting
  • Perihilar Cholangiocarcinoma
  • PD-1antibody plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2022

Metastatic Melanoma to the Groin Lymph Nodes Trial in Worldwide (Inguinal Lymphadenectomy, Ilio-inguinal Lymphadenectomy)

Active, not recruiting
  • Metastatic Melanoma to the Groin Lymph Nodes
  • Inguinal Lymphadenectomy
  • Ilio-inguinal Lymphadenectomy
  • Canberra, Australian Capital Territory, Australia
  • +16 more
Apr 6, 2022

Solid Tumor, Adult, Metastatic Cancer, Soft Tissue Sarcoma Trial in Belgium, France (BT-001, Pembrolizumab [Keytruda])

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • BT-001
  • Pembrolizumab [Keytruda]
  • Brussels, Belgium
  • +4 more
Jul 13, 2022

Breast Tumor Female, Ultrasound Therapy; Complications Trial in Rochester (Research Marker)

Completed
  • Breast Neoplasm Female
  • Ultrasound Therapy; Complications
  • Research Marker
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 17, 2022

Melanoma, Ovarian Cancer, Sarcoma Trial in Italy, Portugal, United States (IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in

Active, not recruiting
  • Melanoma
  • +6 more
  • IGIMRT using a single dose of 24 Gy
  • IGIMRT 27 Gy in 3 fractions
  • San Francisco, California
  • +3 more
Nov 1, 2022

Axillary Lymph Nodes Metastasis in Breast Cancer Patients.

Completed
  • Breast Cancer Female
  • Unenhanced magnetic resonance imaging.
  • Assiut, Egypt
  • +1 more
Jul 30, 2021

Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,

Active, not recruiting
  • Early-Stage Breast Carcinoma
  • Estrogen Receptor Positive Tumor
  • Stockholm, Sweden
  • +2 more
Jul 30, 2021

Breast Cancer Trial in Rozzano (Omission of Axillary dissection)

Recruiting
  • Breast Cancer
  • Omission of Axillary dissection
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Apr 15, 2021

Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)

Suspended
  • Head and Neck Squamous Cell Carcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 16, 2021

18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Dynamic PET/CT
  • (no location specified)
Mar 10, 2022

Breast Cancer, Surgery, Lymph Node Metastases Trial in Hangzhou (Tissue Marker Clip)

Recruiting
  • Breast Cancer
  • +2 more
  • Tissue Marker Clip
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 3, 2021

Esophageal Squamous Cell Carcinoma, Positron Emission Tomography Trial in Zhuhai (Dynamic PET)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Positron Emission Tomography
  • Dynamic PET
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital, Sun Yat-sen University
Feb 2, 2021

Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

Active, not recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Lymph Node Cancer Metastatic Trial in Rozzano (Oligometastatic patients with abdominal-pelvic lymph nodes)

Active, not recruiting
  • Lymph Node Cancer Metastatic
  • Oligometastatic patients with abdominal-pelvic lymph nodes
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Oct 5, 2021

Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester

Recruiting
  • Head and Neck Carcinoma
  • +10 more
  • Scottsdale, Arizona
  • +1 more
Jan 6, 2023

Breast Carcinoma Metastatic in Lymph Node, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial

Completed
  • Breast Carcinoma Metastatic in Lymph Node
  • +5 more
  • Axillary Lymph Node Dissection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2021

Breast Cancer Trial in Rochester (Axillary Magseed)

Terminated
  • Breast Cancer
  • Axillary Magseed
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 8, 2020

Prognostic Value of Lymph Node in ESCC

Completed
  • Esophageal Squamous Cell Carcinoma
  • R0 resection with lymphadenectomy
  • (no location specified)
Feb 19, 2021